Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

SPRO holding history

Spero Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SPRO overviewAll 13F holders of SPROFull Q2 2026 holdings

Shares (Q2 2026)
151
Value
$334
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SPRO by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026151$334<0.1%00.0%UnchangedHolders
Q1 2026151$353<0.1%00.0%UnchangedHolders
Q4 2025151$352<0.1%00.0%UnchangedHolders
Q3 2025151$284<0.1%00.0%UnchangedHolders
Q2 2025151$438<0.1%00.0%UnchangedHolders
Q1 2025151$109<0.1%−5,000−97.1%ReducedHolders
Q4 20245,151$5.31K<0.1%+5,000+3,311.3%AddedHolders
Q3 2024151$202<0.1%00.0%UnchangedHolders
Q2 2024151$196<0.1%00.0%UnchangedHolders
Q1 2024151$260<0.1%00.0%UnchangedHolders
Q4 2023151$222<0.1%00.0%UnchangedHolders
Q3 2023151$183<0.1%00.0%UnchangedHolders
Q2 2023151$219<0.1%00.0%UnchangedHolders
Q1 2023151$219<0.1%00.0%UnchangedHolders
Q4 2022151$261<0.1%00.0%UnchangedHolders
Q3 2022151$00.0%00.0%UnchangedHolders
Q2 2022151$00.0%−1,000−86.9%ReducedHolders
Q1 20221,151$10.0K<0.1%00.0%UnchangedHolders
Q4 20211,151$18.0K<0.1%+151+15.1%AddedHolders
Q3 20211,000$18.0K<0.1%−2,000−66.7%ReducedHolders
Q2 20213,000$42.0K<0.1%00.0%UnchangedHolders
Q1 20213,000$44.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.